Agreement
49th Annual Child Neurology Society Meeting
October-December 2020
Disclosure: It is the policy of the Minnesota Medical Association (MMA) to ensure balance, independence, objectivity, and scientific rigor in its CME activities. To comply with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME), the MMA requires planning committee members and faculty to disclose any relevant financial relationship he/she and his/her spouse/partner has with a commercial interest.
The following financial relationships were disclosed and resolved prior to the activity. They can be found
https://icnapedia.org/icnc2020/overview/speaker-disclosures-2020#disclosures
The remaining members of the faculty and planning committee for this conference have indicated that they have no relevant financial relationships to disclose related to the content of the CME activity. Faculty members have declared that they will uphold the MMA’s standards regarding CME activities and that any clinical recommendations are based on the best available evidence or are consistent with generally accepted medical practice. Please indicate in the comments section of the evaluation form whether you detect any instances of bias toward products manufactured by commercial interests.
CME Credit: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Minnesota Medical Association and the Child Neurology Society. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this activity for a maximum of 100.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: There is no commercial support for this event.
A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients The ACCME defines "'relevant' financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Disclosures
ID
First Name
Last Name
Nature of Financial Relationship
Name of Entity or Entities
1
Gyula
Acsadi (Session Chair)
Consultant - Self, Speaker's Bureau - Self
Speaker's Bureau- Biogen; Consulting- Serepta, Genentech, AveXis/Novartis
2
Mario
Alonso Vanegas
Speaker's Bureau - Self
LIVANOVA
3
Evdokia
Anagnostou
Consultant - Self, Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent), Other, e.g. royalty, employee (Self)
ROCHe, Quadrant, Willey, APPI
4
Adi
Aran
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
BOL Pharma Israel
5
Alexis
Arzimanoglou
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
UCB; EISAI; ZOGENIX; SANOFI; GW as a Consultant in agreement with my Hospital administration
6
Erika
Augustine (Past Program Chair)
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Research support - Abeona Therapeutics; Consultant - BioMarin Pharmaceutical, Regenxbio
7
Stephane
Auvin
Consultant - Self, Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Advice/Expertise: Arvelle, Biomarin, Eisai, GW Pharma, Nutricia, UCB Pharma, Zogenix Lectures: Advicenne Pharma, Biocodex, Eisai, GW Pharma, Nutricia, UCB Pharma, Vitaflo, Zogenix Clinical trials: Advicenne Pharma, Eisai, UCB pharma, Zogenix
8
Edith
Avila Moncayo
Speaker's Bureau - Self
Consejo Mexicano de Neurología A. C.
9
Nancy
Bass
Speaker's Bureau-Self
In 2019 I was part of a speakers bureau for Biogen. This contract terminated December 31, 2019
10
Diana
Bharucha-Goebel
Consultant - Self
Gene Therapy Network - on the steering committee to develop educational material related to gene therapy
11
P.S.
Bindu
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
The Mito Foundation ( Formerly Australian Mitochondrial Disease Foundation). Receives funding from Mito Foundation for a Clinical Research Fellowship
12
Tanuja
Chitnis
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Biogen, Novartis, Sanofi-Genzyme, Roche, Genentech (consulting), Novartis, Octave Biosciences, Mallinckrodt, Verily Life Sciences (research funding)
13
Meeryo
Choe
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Neural Analytics/NIH SBIR
14
Keith
Coffman
Consultant - Self
TEVA-Consultant for a new Tourette Syndrome Medication; Lundbeck-Consultant for a new Tourette Syndrome Medication
15
Bruce
Cohen
Consultant-Self, Honoraria-Self, Speaker's Bureau-Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent, k) Other, e.g. royalty, employee (Self)
Consultant: Stealth Biotherapeutics, Reneo Pharma, NeuroVive Pharma, Modis Pharma Honoraria/Speakers: Stealth Biotherapeutics, American Academy of Neurology CPT Advisor (Honoraria): American Academy of Neurology Grant/Research Support to Employer: Stealth Biotherapeutics, BioElectron Biotechnology Royalty: Elsevier
16
Anne
Connolly (Session Chair)
Consultant - Self
1. Sarepta-Advisory board; NCH Sub I for research studies; 2. Avexis-Advisory board; NCH Sub I for research studies 3. Roche-Advisory board; 4. Acceleron-Advisory board; 5 Catabasis-Data management safety board chair;
17
Helen
Cross
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
International League Against Epilepsy, Nutricia, Vitaflo, Marinius, Zogenix, Ovid, National Institute Health & Research
18
Jim
Dowling
Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Audentes, unrestricted grant in aid; Dynacure, Advisory Board member; RYR1 Foundation,
19
Leon
Dure
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Advisory Board member; DeepGenomics, medical consultant
20
Timothy
Estilow
Consultant - Self, Honoraria - Self
Sarepta Therapeutics and MDA
21
Donald
Gilbert (Session Chair)
Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent), Other, e.g. royalty, employee (Self)
1. US Department of Health and Human Services, expert testimony 2. EryDel Inc., Clinical Trial Site Investigator; 3. Emalex, Clinical Trial Site Investigator; 4. Elsevier: Book Royalties; 5. Wolters Kluwer: Book Royalties. Tourette Association of America/ Centers for Disease Control and Prevention, the Child Neurology Society, and the American Academy of Neurology, U.S. National Vaccine Injury Compensation Program, through the Department of Health and Human Services, Advanced Medical/Teladoc. Dr. Gilbert has received research support from the NIH (NIMH, NINDS). He has received salary compensation through Cincinnati Children’s for work as a clinical trial site investigator from Emalex (clinical trial, Tourette Syndrome) and EryDel (clinical trial, Ataxia Telangiectasia). He has received book royalties from Elsevier and Wolters Kluwer.
22
Christopher
Giza
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent), Stock Shareholder (Self-managed: Self), Other, e.g. royalty, employee (Self)
1.Grants/Research Support: NCAA, U.S. Dept of Defense, UCLA Steve Tisch BrainSPORT program, NIH NINDS (R01 NS110757 2019-2024); UCLA Brain Injury Research Center, Easton Clinic for Brain Health, NINDS Neural Analytics SBIR grant (NS092209 2016-2020) 2.Clinical Consultant: NBA, NFL-Neurological Care Program, NHLPA 3.Advisory Board: Highmark Interactive (2018-2019), Novartis Pharmaceutical (2019), MLS, NBA, USSF. 4.Medicolegal: One or two cases annually 5.Stock Shareholder: Highmark Interactive stock options (2018). 6.Other: Book royalties – Blackwell/Wiley Publishing: Prioritized Neurological Differential Diagnosis
23
Joseph
Gleeson
Consultant - Self
Shire Takeda SHP611
24
Raphaela
Goldbach-Mansky
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Lilly, SOBI
25
Ajay
Gupta
Consultant - Self, Speaker's Bureau - Self
1. Eisai - consultant and speaker bureau 2. Zogenix - advisory board 3. Greenwich Bio - advisory Board. Mallinckrodt
26
Shaun
Hussain
Consultant - Self, Honoraria - Self, Speaker's Bureau - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1. GW Pharma (consultant, research support, speaker's bureau); 2. Insys (consultant, research support); 3. Eisai (consultant, research support); 4. Lundbeck (consultant, research support); 5. Mallinckrodt (consultant, speaker's bureau); 6. Zogenix (research support); 7. Amzell (consultant); 8. Aquestive (consultant); 9. Shennox (consultant); 10. West Therapeutic Development (consultant); 11. Upsher-Smith (consultant)
27
Terrie
Inder
Consultant - Self
Aspect Imaging
28
Shafali
Jeste
Consultant - Self
Roche Pharmaceuticals
29
Mitsuhiro
Kato
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Nobelpharma co.
30
Eric
Kossoff
Consultant - Self, Other, e.g. royalty, employee (Self)
Atkins Nutritionals, Nutricia, Bloom Science (Consultant). UpToDate, Demos, Oxford (book royalties)
31
Nancy
Kuntz
Honoraria - Self, Other, e.g. royalty, employee (Self)
Medical Advisory Boards for Argentyx, Audentes, AveXis, Biogen, Cytokinetics, PTC and Sarepta
32
Richard
Lewis
Consultant - Self, Honoraria - Self
Consultant: CSL Behring, Biotest, Pharnext, Sanofi, Argenx, Annexon, Pfizer, Momenta; Advisory Boards: Akcea, Alnylam; Honorarium: WebMDm
33
Ming
Lim
Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Received consultation fees from CSL Behring, Octapharma and Roche; travel grants from Merck Serono; and awarded educational grants to organize meetings by Novartis, Biogen Idec, Merck Serono and Bayer.
34
Eric
Marsh
Consultant - Self, Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1) Stoke theraputics- Site PI and previous consultant; (2)GW Pharmacuticals- Site PI, Resarch Support; (3)Zogenix Pharmacuticals- Site PI (4) Acadia Pharmacuticals -SIte PI (5) Marinous Pharmacuiticals - Site PI (6)Cilpa Pharmacuticals - one day consultant meeting (7) State of Pennsylvania- Research Support, (8) NIH- research support (9) Eagles Autism Foundation - Research Support; (10) Penn Orphan Disease center- research support (11)RettSyndrome.org - research support (12) International CDKL5 Reserach Foundation- Research Support/Clinical Center of Excellence Support
35
Katherine
Mathews
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Advisory board member: MDA, FSH Society Board member: Friedreich ataxia research alliance (FARA) Research funding: NIH, CDC, FARA Clinical trial funding: PTC Therapeutics, Sarepta Therapeutics, Pfizer, Santhera, Reata, Intalfarmaco, CSL Behring Industry consulting: Sarepta, Santhera, Avexis, PTC (no personal compensation)
36
Jonathan
Mink
a) Consultant-Self, g) Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent
1) Neurogene, Inc - consultant; 2) Amicus, Inc - consultant; 3) Abeona Inc- research contract; 4) Censa Inc - DSMB Chair, Abide Therapeutics
37
Anne Marie
Morse
Speaker's Bureau - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Jazz Pharmaceuticals - speark bureau and investigator regarding narcolepsy and Idiopathic hypersomnia
38
Alysson
Muotri
Other, e.g. royalty, employee (Self)
Tismoo Biotech
39
Jeffrey
Neul
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
OVID-DSMB member, Acadia-Consultant & grant recipient, GW-Consultant & grant recipient, Paraxel-Consultant, AveXis-Consultant
40
Ann
Neumeyer (Session Chair)
Consultant - Self
Finch Therapeutics
41
Adam
Numis
Honoraria - Self
LivaNova, LLC - Honoraria
42
Roger
Packer (Session Chair)
Consultant - Self
Advisory Board Astra Zeneca; Advisory Board Novartis
43
Marc
Patterson
Consultant - Self, Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent), Stock Shareholder (Self-managed: Self)
1. Consulting: Actelion*, Agios*, Alexion*, Amicus*,Cerecor, IntraBio*, Novartis*, Orphazyme*, Shire*, Vtesse*. [Honoraria and/or travel expenses]; 2. Stock: IntraBio; 3. Research: Actelion, Amicus, Idorsia, Glycomine, National MS Society, NIH, Orphazyme, Peggy Furth Fund, Retrotope, Shire
44
Phillip
Pearl
g) Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent
Boston Health Care/PTC Therapeutics
45
Toni
Pearson
Consultant - Self
Teva Pharmaceuticals
46
Alan
Percy (Session Chair)
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Acadia Pharmaceuticals: clinical trial PI and consultant; GW Pharmaceuticals: clinical trial PI; Anavex Pharmaceuticals:clinical trial PI
47
Annapurna
Poduri
Stock Shareholder (Self-managed: Spouse/Partner), Other, e.g. royalty, employee (Spouse/Partner)
Spouse is employed by Sanofi Genzyme and holds stock in the same.
48
Asuri
Prasad (Session Chair)
Honoraria - Self
Eisai as Member of Advisory Board-Brivaricetam in Canada
49
Craig
Press
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1. CR Bard- Consulting, 2. Marinus Pharmaceuticals- Research Support
50
Ronit
Pressler
Consultant - Self, Consultant - Spouse/Partner, Honoraria - Self, Honoraria - Spouse/Partner, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
UCB, Esai
51
Denia
Ramirez-Montealegre
Consultant - Self, Honoraria - Self
Amicus Therapeutics consultant/received honoraria; MEDACorp consultant/received honoraria
52
Margie
Ream
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
I receive funding support receive funding support as Co-Investigator on HRSA/MCHB Task Order Contracts to Support the Advisory Committee on Heritable Disorders in Newborns and Children. (HHSH250201500002I/HHSH25034005T and HHSH250201500002I/HHSH25034006T)
53
Steve
Roach
Honoraria - Self
Elsevier Medical Publishers/ editor
54
Raman
Sankar
Consultant - Self, Honoraria - Self, Speaker's Bureau - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Advisory Board service for: UCB, Sunovion, Eisai, Supernus, Zogenix, Aquestive, BioMarin, Biogen, Encoded Therapeutics
55
Mario
Saporta
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Acceleron, Sarepta, Biogen, SwanBio, Strongbridge, Neurogene, Alnylam, Stealth
56
Ingrid
Scheffer
Consultant - Self, Speaker's Bureau - Self
Biocodex (Participated in Epilepsy Drug Consortium as investigator and Advisory 2019, travel/conference expenses); BioMarin (Honoraria, Travel/Conference expenses 2017/2018/2019); UCB (Travel/Conference, payment for lectures, Chair Scientific Advisory Board, 2017, 2019)
57
Renee
Shellhaas
Honoraria - Self, Other, e.g. royalty, employee (Self)
royalties from UpToDate for authorship of topics related to neonatal seizures; honoraria for a talk to Proctor & Gamble research team
58
Harvey
Singer
Other, e.g. royalty, employee (Self)
Johns Hopkins Solutions
59
Nicola
Specchio
Honoraria - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Biomarin, honoraria and Grant Support, Livanova, honoraria, GW, honoraria, Zogenix, honoraria
60
Sarah
Spence
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Hoffman LaRoche
61
Carl
Stafstrom (Program Chair)
Consultant - Self
Mallinckrodt
62
Ingrid
Tein (ICNA Past President)
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1. Foundation for Prader Willi Research operating grant (PI), 2. Cure JM Foundation (Co-I), 3. CIHR Planning and Dissemination Grant (Co-Applicant))
63
Liu Lin
Thio
Consultant - Self
Epilepsy Study Consortium
64
Haluk
Topaloglu
Honoraria - Self
PTC, Avexis, Sarepta, Biogen advisory boards
65
Keith
Van Haren
Consultant - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Consultant: bluebird bio; Research: bluebird bio, Minoryx
66
Adeline
Vanderver
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1) Eli Lilly- clinical trial support 2) Takeda- grant support 3) Biogen- grant support 4) Gilead- grant support
67
Viviana
Vanegas
Speaker's Bureau - Self
LIVANOVA
68
Mark
Wainwright
a) Consultant-Self
Sage Therapeutics, Member of the Clinical Advisory Board
69
Michael
Wilson
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent), Other, e.g. royalty, employee (Self)
Roche / Genentech grant support; Patent holder on kelch-like protein 11 as a neurological autoimmunity and paraneoplastic marker
70
Elaine
Wirrell
Consultant - Self
Biomarin, Biocodex
71
Courtney
Wusthoff (Session Chair)
Consultant - Self
Persyst Software- consultant
72
Ann
Yeh (Co-Chair)
Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
Alexion (clinical trial), Roche (clinical trial), Biogen (investigator initiated research study), Roche (advisory board), Alexion (advisory/scientific board)
73
Mary
Zupanc
Speaker's Bureau - Self, Grant/Research Support (Self: Principle Investigator or working directly for company/company's agent)
1. Mallinckrodt Pharma---from Mallinckrodt, Speaker's Bureau for Mallinckrodt. 2. Aquestive Pharmaceuticals---Speaker's bureau 3. Greenwich Biosciences--Speaker's bureau 4. Zogenix pharma.